AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Alamo Group Inc.

$169.08 -$1.35 (-0.79%)
NYSE · 11 Sep 2026 20:00 UTC
Previous Close
$167.28
Day Range
$167.53$171.48
Year Range
$145.76$219.88
Market Cap
2.06B
AVG Volume
174.78K
Trailing/Forward PE
20.15/13.89
PEG ratio
1.31
Dividend Yield
0.78%
Next Earnings Date
2026-11-05
Primary Exchange
New York Stock ExchangeUS
Revenue (USD) · TTM
0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ALG Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q21.66B
26 Q11.63B
25 Q41.6B
25 Q31.62B
25 Q21.6B
25 Q11.59B
24 Q41.63B
24 Q31.66B
24 Q21.68B
24 Q11.7B
Net Income (USD) · TTM
050M100M150M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ALG Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2101.02M
26 Q1101.19M
25 Q4103.8M
25 Q3116.37M
25 Q2118.39M
25 Q1115.61M
24 Q4115.93M
24 Q3119.37M
24 Q2126.88M
24 Q1134.93M
Operating Income (USD) · TTM
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ALG Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2148M
26 Q1149.31M
25 Q4151.61M
25 Q3163.52M
25 Q2166.06M
25 Q1162.29M
24 Q4164.81M
24 Q3175.16M
24 Q2184.84M
24 Q1195.92M
EBITDA (USD) · TTM
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ALG EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2235.58M
26 Q1248.14M
25 Q4248.37M
25 Q3221.74M
25 Q2222.89M
25 Q1220.92M
24 Q4223.26M
24 Q3231.36M
24 Q2239.75M
24 Q1248.21M
Cash Flows (USD) · TTM
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ALG Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2135.31M
26 Q1110.7M
25 Q4146.92M
25 Q3149.92M
25 Q2185.24M
25 Q1198.27M
24 Q4184.55M
24 Q3155.08M
24 Q297.72M
24 Q195.67M
EPS (USD) · TTM
05101524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ALG EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q28.34
26 Q18.36
25 Q48.59
25 Q39.64
25 Q29.82
25 Q19.6
24 Q49.63
24 Q39.93
24 Q210.56
24 Q111.24
Expenses (USD) · TTM
0100M200M300MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ALG Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q2269.61M
26 Q1267.82M
25 Q4265.88M
25 Q3256.33M
25 Q2248.64M
25 Q1249.77M
24 Q4256.68M
24 Q3267.91M
24 Q2272.61M
24 Q1276.48M
Shares Outstanding (USD) · TTM
-20M-10M010M20MBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ALG Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q23.26M
26 Q1-6.67M
25 Q4-6.92M
25 Q3-7.27M
25 Q2-7.26M
25 Q1-7.35M
24 Q4-7.17M
24 Q3-7.29M
24 Q2-6.75M
24 Q1-5.93M
Dividends (USD)
00.10.20.30.4Apr 24Jul 24Oct 24Jan 25Apr 25Jul 25Oct 25Jan 26Apr 26Jul 26
ALG Dividends (USD) by quarter
PeriodDividends (USD)
Jul 260.34
Apr 260.34
Jan 260.34
Oct 250.3
Jul 250.3
Apr 250.3
Jan 250.3
Oct 240.26
Jul 240.26
Apr 240.26
Employee Count
02K4K6K2016201720182019202020212022202320242025
ALG Employee Count by quarter
PeriodEmployee Count
20253.8K
20243.75K
20234.35K
20224.2K
20214.2K
20203.99K
20194.27K
20183.47K
20173.28K
20162.9K
PE Ratio
1618202224med 19.46Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ALG PE Ratio by quarter
PeriodPE Ratio
Sep 2620.19
Sep 2620.72
Aug 2619.73
Aug 2619.63
Aug 2619.69
Aug 2620.14
Jul 2618.95
Jul 2619.69
Jul 2619.35
Jul 2619.23
Jul 2620.28
Jun 2620.1
Jun 2619.22
Jun 2618.31
Jun 2617.79
May 2617.95
May 2617.87
May 2617.54
May 2619.5
May 2619.84
Apr 2619.9
Apr 2619.93
Apr 2620.48
Apr 2619.47
Mar 2619.34
Mar 2618.5
Mar 2619.77
Mar 2619.47
Feb 2622.07
Feb 2622.07
Feb 2621.79
Feb 2621.54
Jan 2620.19
Jan 2619.76
Jan 2619.91
Jan 2619.32
Jan 2617.62
Dec 2518.02
Dec 2517.97
Dec 2518.33
Dec 2517.04
Nov 2516.58
Nov 2516.64
Nov 2516.79
Nov 2517.25
Oct 2518.14
Oct 2519.1
Oct 2518.36
Oct 2518.53
Oct 2519.46
Sep 2519.56
Sep 2520.15
Sep 2520.88
Sep 2521.24
Aug 2521.47
Aug 2522.49
Aug 2522.57
Aug 2522.6
Aug 2522.36
Jul 2522.77
Jul 2522.52
Jul 2523.43
Jul 2523.46
Jun 2522.52
Jun 2522.25
Jun 2522.03
Jun 2521.48
May 2520.54
May 2520.43
May 2521.07
May 2519.85
May 2517.98
Apr 2517.42
Apr 2517.3
Apr 2517.68
Apr 2517.13
Mar 2518.69
Mar 2518.97
Mar 2519.21
Mar 2518.98
Feb 2518.08
Feb 2518.95
Feb 2518.52
Feb 2518.56
Jan 2518.62
Jan 2518.61
Jan 2518.3
Jan 2517.35
Jan 2518.26
Dec 2418.6
Dec 2418.9
Dec 2419.37
Dec 2419.67
Nov 2420.06
Nov 2419.88
Nov 2419.5
Nov 2419.62
Nov 2418.81
Oct 2416.21
Oct 2416.75
Free Cash Flow Yield
4%6%8%10%med 7.11%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ALG Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 266.64%
Sep 266.46%
Aug 266.79%
Aug 266.82%
Aug 266.8%
Aug 266.65%
Jul 265.77%
Jul 265.56%
Jul 265.66%
Jul 265.69%
Jul 265.4%
Jun 265.44%
Jun 265.69%
Jun 265.98%
Jun 266.15%
May 266.1%
May 266.12%
May 266.24%
May 265.61%
May 267.13%
Apr 267.11%
Apr 267.1%
Apr 266.91%
Apr 267.27%
Mar 267.32%
Mar 267.65%
Mar 267.16%
Mar 267.27%
Feb 265.84%
Feb 265.84%
Feb 265.91%
Feb 265.98%
Jan 266.38%
Jan 266.52%
Jan 266.47%
Jan 266.67%
Jan 267.31%
Dec 257.15%
Dec 257.17%
Dec 257.03%
Dec 257.56%
Nov 257.77%
Nov 257.74%
Nov 257.67%
Nov 257.47%
Oct 258.62%
Oct 258.19%
Oct 258.52%
Oct 258.44%
Oct 258.04%
Sep 258%
Sep 257.77%
Sep 257.49%
Sep 257.37%
Aug 257.29%
Aug 256.96%
Aug 256.93%
Aug 256.92%
Aug 257.67%
Jul 257.53%
Jul 257.62%
Jul 257.32%
Jul 257.31%
Jun 257.62%
Jun 257.71%
Jun 257.78%
Jun 257.98%
May 258.35%
May 258.39%
May 258.14%
May 258.64%
May 258.86%
Apr 259.14%
Apr 259.2%
Apr 259%
Apr 259.29%
Mar 258.52%
Mar 258.39%
Mar 258.29%
Mar 258.39%
Feb 258.8%
Feb 256.85%
Feb 257.02%
Feb 257%
Jan 256.98%
Jan 256.98%
Jan 257.1%
Jan 257.49%
Jan 257.11%
Dec 246.98%
Dec 246.88%
Dec 246.71%
Dec 246.6%
Nov 246.48%
Nov 246.54%
Nov 246.66%
Nov 246.62%
Nov 246.91%
Oct 244.75%
Oct 244.6%
Price to Sales
11.21.41.61.8med 1.33Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ALG Price to Sales by quarter
PeriodPrice to Sales
Sep 261.23
Sep 261.26
Aug 261.2
Aug 261.19
Aug 261.2
Aug 261.22
Jul 261.18
Jul 261.22
Jul 261.2
Jul 261.19
Jul 261.26
Jun 261.25
Jun 261.19
Jun 261.14
Jun 261.1
May 261.11
May 261.11
May 261.09
May 261.21
May 261.28
Apr 261.29
Apr 261.29
Apr 261.33
Apr 261.26
Mar 261.25
Mar 261.2
Mar 261.28
Mar 261.26
Feb 261.59
Feb 261.59
Feb 261.57
Feb 261.55
Jan 261.45
Jan 261.42
Jan 261.43
Jan 261.39
Jan 261.27
Dec 251.3
Dec 251.29
Dec 251.32
Dec 251.23
Nov 251.19
Nov 251.2
Nov 251.21
Nov 251.24
Oct 251.35
Oct 251.42
Oct 251.36
Oct 251.37
Oct 251.44
Sep 251.45
Sep 251.49
Sep 251.55
Sep 251.58
Aug 251.59
Aug 251.67
Aug 251.67
Aug 251.68
Aug 251.62
Jul 251.65
Jul 251.63
Jul 251.7
Jul 251.7
Jun 251.63
Jun 251.61
Jun 251.6
Jun 251.56
May 251.49
May 251.48
May 251.53
May 251.44
May 251.28
Apr 251.24
Apr 251.23
Apr 251.26
Apr 251.22
Mar 251.33
Mar 251.35
Mar 251.37
Mar 251.35
Feb 251.29
Feb 251.36
Feb 251.33
Feb 251.33
Jan 251.34
Jan 251.34
Jan 251.32
Jan 251.25
Jan 251.31
Dec 241.34
Dec 241.36
Dec 241.39
Dec 241.41
Nov 241.44
Nov 241.43
Nov 241.4
Nov 241.41
Nov 241.35
Oct 241.23
Oct 241.27
EV/EBITDA
68101214med 9.82Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ALG EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 268.99
Sep 269.22
Aug 268.79
Aug 268.75
Aug 268.77
Aug 268.97
Jul 268.11
Jul 268.41
Jul 268.27
Jul 268.23
Jul 268.65
Jun 268.58
Jun 268.22
Jun 267.85
Jun 267.64
May 267.7
May 267.67
May 267.54
May 268.34
May 267.93
Apr 267.96
Apr 267.97
Apr 268.2
Apr 267.78
Mar 267.72
Mar 267.37
Mar 267.9
Mar 267.78
Feb 2611.42
Feb 2611.42
Feb 2611.28
Feb 2611.14
Jan 2610.44
Jan 2610.21
Jan 2610.29
Jan 269.98
Jan 269.09
Dec 259.3
Dec 259.27
Dec 259.46
Dec 258.78
Nov 258.54
Nov 258.58
Nov 258.65
Nov 258.89
Oct 259.69
Oct 2510.19
Oct 259.8
Oct 259.9
Oct 2510.39
Sep 2510.44
Sep 2510.75
Sep 2511.14
Sep 2511.33
Aug 2511.45
Aug 2512
Aug 2512.04
Aug 2512.05
Aug 2511.78
Jul 2511.99
Jul 2511.86
Jul 2512.34
Jul 2512.35
Jun 2511.86
Jun 2511.72
Jun 2511.61
Jun 2511.32
May 2510.82
May 2510.77
May 2511.1
May 2510.46
May 259.47
Apr 259.18
Apr 259.12
Apr 259.31
Apr 259.03
Mar 259.84
Mar 259.98
Mar 2510.11
Mar 259.99
Feb 259.52
Feb 2510.14
Feb 259.92
Feb 259.94
Jan 259.97
Jan 259.97
Jan 259.8
Jan 259.31
Jan 259.79
Dec 249.96
Dec 2410.11
Dec 2410.36
Dec 2410.51
Nov 2410.71
Nov 2410.62
Nov 2410.42
Nov 2410.49
Nov 2410.07
Oct 249.31
Oct 249.6
Price/Operating Cashflow
81012141618med 11.9Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ALG Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2612.49
Sep 2612.82
Aug 2612.21
Aug 2612.14
Aug 2612.18
Aug 2612.46
Jul 2613.71
Jul 2614.25
Jul 2614
Jul 2613.92
Jul 2614.67
Jun 2614.55
Jun 2613.91
Jun 2613.25
Jun 2612.87
May 2612.99
May 2612.93
May 2612.69
May 2614.11
May 2611.6
Apr 2611.64
Apr 2611.65
Apr 2611.97
Apr 2611.39
Mar 2611.3
Mar 2610.82
Mar 2611.56
Mar 2611.38
Feb 2614.15
Feb 2614.14
Feb 2613.97
Feb 2613.81
Jan 2612.94
Jan 2612.66
Jan 2612.76
Jan 2612.38
Jan 2611.29
Dec 2511.55
Dec 2511.52
Dec 2511.75
Dec 2510.92
Nov 2510.63
Nov 2510.67
Nov 2510.76
Nov 2511.06
Oct 2510.12
Oct 2510.65
Oct 2510.23
Oct 2510.33
Oct 2510.85
Sep 2510.9
Sep 2511.23
Sep 2511.64
Sep 2511.84
Aug 2511.97
Aug 2512.54
Aug 2512.58
Aug 2512.6
Aug 2511.6
Jul 2511.81
Jul 2511.68
Jul 2512.16
Jul 2512.17
Jun 2511.68
Jun 2511.54
Jun 2511.43
Jun 2511.15
May 2510.65
May 2510.6
May 2510.93
May 2510.3
May 259.93
Apr 259.62
Apr 259.56
Apr 259.77
Apr 259.47
Mar 2510.33
Mar 2510.48
Mar 2510.62
Mar 2510.49
Feb 259.99
Feb 2512.25
Feb 2511.96
Feb 2511.99
Jan 2512.03
Jan 2512.03
Jan 2511.82
Jan 2511.21
Jan 2511.8
Dec 2412.02
Dec 2412.21
Dec 2412.52
Dec 2412.71
Nov 2412.96
Nov 2412.84
Nov 2412.6
Nov 2412.68
Nov 2412.15
Oct 2416.03
Oct 2416.57
Price to Book
1.522.53med 2.05Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ALG Price to Book by quarter
PeriodPrice to Book
Sep 261.72
Sep 261.76
Aug 261.68
Aug 261.67
Aug 261.67
Aug 261.71
Jul 261.63
Jul 261.7
Jul 261.67
Jul 261.66
Jul 261.75
Jun 261.73
Jun 261.66
Jun 261.58
Jun 261.53
May 261.55
May 261.54
May 261.51
May 261.68
May 261.79
Apr 261.8
Apr 261.8
Apr 261.85
Apr 261.76
Mar 261.75
Mar 261.67
Mar 261.79
Mar 261.76
Feb 262.27
Feb 262.27
Feb 262.24
Feb 262.21
Jan 262.07
Jan 262.03
Jan 262.05
Jan 261.99
Jan 261.81
Dec 251.85
Dec 251.85
Dec 251.88
Dec 251.75
Nov 251.7
Nov 251.71
Nov 251.73
Nov 251.77
Oct 251.93
Oct 252.03
Oct 251.95
Oct 251.97
Oct 252.07
Sep 252.08
Sep 252.14
Sep 252.22
Sep 252.25
Aug 252.28
Aug 252.39
Aug 252.4
Aug 252.4
Aug 252.45
Jul 252.49
Jul 252.46
Jul 252.56
Jul 252.57
Jun 252.46
Jun 252.43
Jun 252.41
Jun 252.35
May 252.25
May 252.23
May 252.3
May 252.17
May 252.05
Apr 251.98
Apr 251.97
Apr 252.01
Apr 251.95
Mar 252.13
Mar 252.16
Mar 252.19
Mar 252.16
Feb 252.06
Feb 252.22
Feb 252.17
Feb 252.18
Jan 252.18
Jan 252.18
Jan 252.15
Jan 252.03
Jan 252.14
Dec 242.18
Dec 242.22
Dec 242.27
Dec 242.31
Nov 242.35
Nov 242.33
Nov 242.29
Nov 242.3
Nov 242.21
Oct 242.1
Oct 242.17
Alamo Group Inc.
ALG
Stockpicker

Video analysis: ALG

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ALG

Timken (NYSE:TKR) versus Alamo Group (NYSE:ALG) Head to Head Review

defenseworld.net · 9 Sep 2026

Timken (NYSE:TKR) versus Alamo Group (NYSE:ALG) Head to Head Review

Alamo Group (NYSE: ALG - Get Free Report) and Timken (NYSE: TKR - Get Free Report) are both mid-cap industrials companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership and risk. Dividends Alamo Group pays an annual dividend of

Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China

globenewswire.com · 12 Aug 2026

Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China

SOUTH SAN FRANCISCO, Calif., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that dosing has been initiated in the Phase 1 study of ALG-170675, an investigational next-generation antisense oligonucleotide (ASO) being evaluated for functional cure in the treatment of chronic hepatitis B virus (HBV) infection. The study is being conducted in China by Xiamen Amoytop Biotech Co., Ltd. (“Amoytop”), who maintain rights in Greater China.

Zacks Industry Outlook Deere, Kubota, CNH, AGCO and Alamo

zacks.com · 5 Aug 2026

Zacks Industry Outlook Deere, Kubota, CNH, AGCO and Alamo

Deere, Kubota, CNH, AGCO and Alamo have been highlighted in this Industry Outlook article.

Alamo Group Inc. (ALG) Q2 2026 Earnings Call Transcript

seekingalpha.com · 4 Aug 2026

Alamo Group Inc. (ALG) Q2 2026 Earnings Call Transcript

Alamo Group Inc. (ALG) Q2 2026 Earnings Call Transcript

Alamo Group Q2 Earnings Call Highlights

marketbeat.com · 4 Aug 2026

Alamo Group Q2 Earnings Call Highlights

Alamo Group NYSE: ALG reported second-quarter 2026 net sales of $415.7 million, up 7.6% from a year earlier, as acquisitions and modest organic growth supported results. Organic net sales rose 1.3%, while adjusted diluted earnings per share increased 7.2% to $2.82.

5 Farm Equipment Stocks to Watch as Industry Shows Promise

zacks.com · 4 Aug 2026

5 Farm Equipment Stocks to Watch as Industry Shows Promise

The Manufacturing - Farm Equipment industry stocks DE, KUBTY, CNH, AGCO and ALG are set to benefit from demand for agricultural machinery driven by the need to feed a growing global population.

Alamo Group (ALG) Tops Q2 Earnings and Revenue Estimates

zacks.com · 3 Aug 2026

Alamo Group (ALG) Tops Q2 Earnings and Revenue Estimates

Alamo Group (ALG) came out with quarterly earnings of $2.82 per share, beating the Zacks Consensus Estimate of $2.74 per share. This compares to earnings of $2.57 per share a year ago.

ALAMO GROUP ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER 2026

prnewswire.com · 3 Aug 2026

ALAMO GROUP ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER 2026

SEGUIN, Texas, Aug. 3, 2026 /PRNewswire/ -- Alamo Group Inc. (NYSE: ALG) today reported results for the second quarter of 2026. Highlights:   Net sales were $450.7 million, up 7.6% compared to the second quarter of 2025 Net income was $30.9 million and adjusted net income was $34.2 million Fully diluted EPS was $2.55 per share, nearly flat compared to $2.57 per share in the second quarter of 2025 Adjusted fully diluted EPS was $2.82 per share, an increase of 7.2% compared to $2.63 per share in the second quarter of 2025 Adjusted EBITDA of $63.9 million was 14.2% of net sales, up 8.7% compared to the second quarter of 2025 Net sales in the Industrial Equipment Division were $271.6 million, up 12.8% compared to the second quarter of 2025 Net sales in the Vegetation Management Division were $179.1 million, up 0.4% compared to the second quarter of 2025 The Company renewed its credit facility in May 2026 with improved terms and preserved $602.5 million of committed capacity, including a $400.0 million revolver and $202.5 million term loan facility On June 30, 2026, cash was $195.0 million and total debt was $262.7 million  Returned $19.0 million to stockholders in the first six months of 2026, including $10.8 million of share repurchases and $8.2 million of dividends Robert Hureau, Alamo Group's President and Chief Executive Officer, commented, "Our second quarter results reflect continued execution across the business, highlighted by strong sales growth in our Industrial Equipment Division, improved adjusted earnings, and solid adjusted EBITDA performance.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.